ConductScience.org, home

Paper41103296

Metabolomic profiling reveals novel biomarkers and therapeutic targets in Legg-Calvé-Perthes disease: a comprehensive analysis of peripheral blood and endothelial function.

Zi S and 7 others. Front Physiol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Metabolomic profiling reveals novel biomarkers and therapeutic targets in Legg-Calvé-Perthes disease: a comprehensive analysis of peripheral blood and endothelial function. Papers, record 41103296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41103296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolomic profiling reveals novel biomarkers and therapeutic targets in Legg-Calvé-Perthes disease: a comprehensive analysis of peripheral blood and endothelial function.
PubMed
Journal
Front Physiol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-10-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zi SShaoneng
2Wang CChengyong
3Zhang TTong
4Lv QQian
5Wan ZZhiying
6He PPengju
7Hang YYong
8Xu YYongqing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133843788Hip Morphology in Early-stage LCPD: Is There an Argument for Anatomic-specific Containment?J Pediatr Orthop2021https://conductscience.org/library/papers/33843788PubMed
236274080Development of acetabular retroversion in LCPD hips-an observational radiographic study from early stage to healing.Arch Orthop Trauma Surg2023https://conductscience.org/library/papers/36274080PubMed
335628529Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.Int J Mol Sci2022https://conductscience.org/library/papers/35628529PubMed
433573577Sanguinarine: A Double-Edged Sword of Anticancer and Carcinogenesis and Its Future Application Prospect.Anticancer Agents Med Chem2021https://conductscience.org/library/papers/33573577PubMed
538315432Legg-Calvé-Perthes Disease: Diagnosis, Decision Making, and Outcome.Curr Sports Med Rep2024https://conductscience.org/library/papers/38315432PubMed
640108238Metabolomic profiles in serum uncover novel biomarkers in children with Williams-Beuren syndrome.Sci Rep2025https://conductscience.org/library/papers/40108238PubMed
733938444Surgical Treatments for Legg-Calvé-Perthes Disease: Comprehensive Review.Interact J Med Res2021https://conductscience.org/library/papers/33938444PubMed
837417786A microfluidic platform integrating dynamic cell culture and dielectrophoretic manipulation for in situ assessment of endothelial cell mechanics.Lab Chip2023https://conductscience.org/library/papers/37417786PubMed
929155310Legg-Calvé-Perthes disease.Orthop Traumatol Surg Res2018https://conductscience.org/library/papers/29155310PubMed
1032526406The role of miR-150 regulates bone cell differentiation and function.Bone2021https://conductscience.org/library/papers/32526406PubMed
1133220290Increased circulating CD31+/CD42b-EMPs in Perthes disease and inhibit HUVECs angiogenesis via endothelial dysfunction.Life Sci2021https://conductscience.org/library/papers/33220290PubMed
1233809098Potential Effect of Pseudevernia furfuracea (L.) Zopf Extract and Metabolite Physodic Acid on Tumour Microenvironment Modulation in MCF-10A Cells.Biomolecules2021https://conductscience.org/library/papers/33809098PubMed
1334740784MicroRNA sequence analysis of plasma exosomes in early Legg-Calvé-Perthes disease.Cell Signal2022https://conductscience.org/library/papers/34740784PubMed
1437422572[Legg-Calvé-Perthes disease].Radiologie (Heidelb)2023https://conductscience.org/library/papers/37422572PubMed
1529727671Metabolomics and Isotope Tracing.Cell2018https://conductscience.org/library/papers/29727671PubMed
1635292045Legg-Calvé-Perthes disease overview.Orphanet J Rare Dis2022https://conductscience.org/library/papers/35292045PubMed
1736300786In vitrovascularization of hydrogel-based tissue constructs via a combined approach of cell sheet engineering and dynamic perfusion cell culture.Biofabrication2022https://conductscience.org/library/papers/36300786PubMed
1837303951Construction of ceRNA network based on RNA-seq for identifying prognostic lncRNA biomarkers in Perthes disease.Front Genet2023https://conductscience.org/library/papers/37303951PubMed
1928106508GelMA-Encapsulated hDPSCs and HUVECs for Dental Pulp Regeneration.J Dent Res2017https://conductscience.org/library/papers/28106508PubMed
2036988742Combined targeted and untargeted high-resolution mass spectrometry analyses to investigate metabolic alterations in pompe disease.Metabolomics2023https://conductscience.org/library/papers/36988742PubMed

See all 21 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41103296

GET https://conductscience.org/api/papers/v1/41103296/references?page=2